Key Events This Week
21 Sep: Stock opens strong at Rs.466.45 (+5.31%)
22 Sep: New 52-week high at Rs.485 and all-time high close at Rs.482.80
23 Sep: Minor correction with slight dip to Rs.482.80 (-0.03%)
24 Sep: Decline to Rs.474.55 (-1.71%) amid broader market weakness
25 Sep: Week closes at Rs.474.85 (+0.06%)
21 September 2026: Strong Opening Momentum
SMS Pharmaceuticals Ltd began the week with a robust gain of 5.31%, closing at Rs.466.45 on 21 September. This surge outpaced the Sensex’s modest 0.46% rise to 35,787.64 points. The volume of 79,722 shares indicated healthy market participation, setting a positive tone for the week ahead. The stock’s upward momentum was supported by technical strength, trading above key moving averages and signalling a bullish trend.
22 September 2026: New 52-Week and All-Time Highs
The highlight of the week came on 22 September when SMS Pharmaceuticals Ltd hit a new 52-week high of Rs.485 intraday and closed at an all-time high of Rs.482.80, marking a 3.54% daily gain. This performance significantly outperformed the Sensex, which declined by 0.32% to 35,672.04 points. The stock’s rally was driven by sustained buying interest and strong technical signals, including bullish MACD and KST indicators on weekly and monthly charts.
Volume remained elevated at 74,560 shares, reflecting increased market activity. The stock’s premium valuation metrics, including a trailing P/E of 43x and EV/EBITDA of 27.20x, underscore investor confidence despite a Mojo Grade of Sell. The company’s long-term growth trajectory remains impressive, with a 70.42% gain over the past year and a three-year return nearing 295%.
Rising fast and still accelerating! This Small Cap from FMCG sector is riding pure momentum right now. Jump in before the rally reaches its peak!
- - Accelerating price action
- - Pure momentum play
- - Pre-peak entry opportunity
23 September 2026: Slight Pullback Amid Market Gains
On 23 September, the stock experienced a marginal decline of 0.03%, closing at Rs.482.80, essentially flat compared to the previous day’s close. This minor correction occurred despite the Sensex gaining 0.56% to 35,870.78 points. The volume dropped to 44,864 shares, suggesting a pause in the intense buying seen earlier in the week. The stock remained above all major moving averages, maintaining its bullish technical posture.
24 September 2026: Market Weakness Weighs on Stock
SMS Pharmaceuticals Ltd declined by 1.71% to close at Rs.474.55 on 24 September, underperforming the Sensex which fell 1.62% to 35,291.38 points. The sharp market correction was reflected in the stock’s lower volume of 19,896 shares. Despite this setback, the stock’s technical indicators continued to signal medium-term strength, with support levels holding above Rs.470. The decline was consistent with broader market weakness and profit-taking after the recent rally.
25 September 2026: Week Ends on a Stable Note
The week concluded with a modest gain of 0.06%, as SMS Pharmaceuticals Ltd closed at Rs.474.85 on 25 September. The Sensex also recovered slightly, rising 0.18% to 35,353.29 points. Volume increased to 45,708 shares, indicating renewed interest. The stock’s ability to hold near the week’s highs despite volatile market conditions highlights its relative resilience and sustained investor confidence.
Holding SMS Pharmaceuticals Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-09-21 | Rs.466.45 | +5.31% | 35,787.64 | +0.46% |
| 2026-09-22 | Rs.482.95 | +3.54% | 35,672.04 | -0.32% |
| 2026-09-23 | Rs.482.80 | -0.03% | 35,870.78 | +0.56% |
| 2026-09-24 | Rs.474.55 | -1.71% | 35,291.38 | -1.62% |
| 2026-09-25 | Rs.474.85 | +0.06% | 35,353.29 | +0.18% |
Key Takeaways
SMS Pharmaceuticals Ltd demonstrated strong relative strength this week, gaining 7.20% against a 0.76% decline in the Sensex. The stock’s ability to hit new 52-week and all-time highs on 22 September was a pivotal moment, supported by bullish technical indicators such as MACD, KST, and sustained trading above all major moving averages.
Volume trends showed increased market participation during the rally, with delivery volumes rising significantly in recent sessions. Despite a premium valuation reflected in a trailing P/E of 43x and EV/EBITDA of 27.20x, the stock’s long-term returns remain impressive, with a 295.41% gain over three years and nearly 385% over ten years.
However, some caution is warranted given the company’s below-average quality metrics, including modest EBIT growth and relatively low institutional holdings. The recent short-term financials showed mixed results, with a 31.39% growth in six-month PAT but a quarterly decline in profit and sales. The stock’s RSI indicator on weekly charts also signals some short-term caution.
Conclusion
SMS Pharmaceuticals Ltd’s performance this week highlights a phase of strong momentum and technical strength, marked by significant price milestones and outperformance relative to the broader market. While valuation and quality metrics suggest a cautious fundamental backdrop, the stock’s sustained rally and robust trading volumes underscore its prominent position within the Pharmaceuticals & Biotechnology sector. Investors should monitor upcoming financial results and technical signals to gauge the sustainability of this momentum.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
